blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2298807

EP2298807 - Antibodies directed against amyloid-beta peptide and methods using same [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.03.2018
Database last updated on 30.09.2024
FormerGrant of patent is intended
Status updated on  15.06.2017
FormerExamination is in progress
Status updated on  07.12.2016
Most recent event   Tooltip23.03.2018Application deemed to be withdrawnpublished on 25.04.2018  [2018/17]
Applicant(s)For all designated states
Rinat Neuroscience Corp.
230 East Grand Avenue
South San Francisco, CA 94080 / US
[2011/12]
Inventor(s)01 / Rosenthal, Arnon
150 Normandy Lane
Woodside, CA 94062 / US
02 / Pons, Jaume
Rinat Research Pfizer Inc 230 East Grand Avenue
South San Francisco, CA 94080 / US
03 / Ho, Wei-Hsien
153 California Avenue F211
Palo Alto, CA 94306 / US
04 / Grimm, Jan, Markus
643 18th Avenue
Menlo Park, CA 94025 / US
 [2011/16]
Former [2011/12]01 / Rosenthal, Arnon
150 Normandy Lane
Woodside, CA 94062 / US
02 / Pons, Jaume
3311 La Mesa Drive 3
San Carlos, CA 94070 / US
03 / Ho, Wei-Hsien
153 California Avenue F211
Palo Alto, CA 94306 / US
04 / Grimm, Jan, Markus
643 18th Avenue
Menlo Park, CA 94025 / US
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2012/33]
Former [2011/12]Porter, Jonathan Philip, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date10184193.001.08.2005
[2011/12]
Priority number, dateUS20040592494P30.07.2004         Original published format: US 592494 P
US20050653197P14.02.2005         Original published format: US 653197 P
US20050676093P29.04.2005         Original published format: US 676093 P
[2011/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2298807
Date:23.03.2011
Language:EN
[2011/12]
Type: A3 Search report 
No.:EP2298807
Date:18.05.2011
[2011/20]
Search report(s)(Supplementary) European search report - dispatched on:EP15.04.2011
ClassificationIPC:C07K16/18, A61P25/00
[2011/12]
CPC:
C07K16/18 (EP,KR,US); A61K39/00 (EP,KR,US); A61P25/00 (EP);
A61P25/28 (EP); A61P43/00 (EP); C07K16/00 (EP,KR,US);
A61K2039/505 (EP,US); C07K2317/21 (EP,US); C07K2317/24 (EP,US);
C07K2317/41 (EP,US); C07K2317/52 (EP,US); C07K2317/55 (EP,US);
C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/92 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/12]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:Gegen das Amyloid-beta-Peptid gerichtete Antikörper und Verfahren zu deren Anwendung[2011/12]
English:Antibodies directed against amyloid-beta peptide and methods using same[2011/12]
French:Anticorps anti peptide amyloide beta, et leurs procedes d' utilisation[2011/12]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure18.11.2011Examination requested  [2011/52]
06.03.2012Amendment by applicant (claims and/or description)
18.10.2013Despatch of a communication from the examining division (Time limit: M06)
28.04.2014Reply to a communication from the examining division
28.05.2015Despatch of a communication from the examining division (Time limit: M06)
07.12.2015Reply to a communication from the examining division
27.07.2016Despatch of a communication from the examining division (Time limit: M06)
05.01.2017Reply to a communication from the examining division
14.06.2017Communication of intention to grant the patent
25.10.2017Application deemed to be withdrawn, date of legal effect  [2018/17]
29.11.2017Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2018/17]
Parent application(s)   TooltipEP05778628.7  / EP1781704
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050778628) is  15.02.2008
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
06.03.2012Request for further processing filed
06.03.2012Full payment received (date of receipt of payment)
Request granted
19.03.2012Decision despatched
Fees paidRenewal fee
30.09.2010Renewal fee patent year 03
30.09.2010Renewal fee patent year 04
30.09.2010Renewal fee patent year 05
30.09.2010Renewal fee patent year 06
31.08.2011Renewal fee patent year 07
31.08.2012Renewal fee patent year 08
02.09.2013Renewal fee patent year 09
01.09.2014Renewal fee patent year 10
31.08.2015Renewal fee patent year 11
31.08.2016Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
31.08.201713   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO9958572  (UNIV CAMBRIDGE TECH [GB], et al);
 [X]EP1172378  (DODEL RICHARD DR [DE], et al);
 [XYI]WO03077858  (NEURALAB LTD, et al);
 [AD]WO03086310  (UNIV RAMOT [IL], et al);
 [YD]US2004146512  (ROSENTHAL ARNON [US], et al);
 [E]WO2005120571  (UNIV RAMOT [IL], et al);
by applicantEP0003089
 US4676980
 US4683195
 US4683202
 WO8704462
 US4754065
 GB2200651
 US4777127
 US4800159
 US4816567
 EP0345242
 WO9007936
 WO9011092
 WO9100360
 WO9102805
 US5047335
 WO9114445
 WO9220373
 EP0524968
 WO9303769
 WO9310218
 WO9311230
 US5219740
 US5225539
 WO9319191
 WO9325698
 WO9325234
 US5278299
 WO9403622
 WO9404690
 WO9412649
 WO9423697
 WO9428938
 WO9500655
 WO9507994
 WO9511984
 WO9513796
 US5422120
 WO9530763
 US5500362
 US5510261
 WO9617072
 US5530101
 US5545807
 US5545806
 US5569825
 US5580859
 US5585089
 US5625126
 US5633425
 US5661016
 US5677425
 WO9742338
 US5693761
 US5693762
 US5750373
 US5807715
 US5814482
 US5821337
 US5866692
 WO9927944
 WO9958572
 US5997867
 WO0072880
 WO0072876
 US6180370
 US6331415
 US6376471
 US6413942
 US6436908
 US6548640
 US2003147887
 US2003165496
 WO03086310
 WO03104437
 WO2004032868
 US2004087777
 WO2004058184
 US2004146512
 US2004219146
 GB19980009951
 WO1999GB01441
 US20030683815
 WO2003US32080
 US20050676093
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.